Creatine promotes the GABAergic phenotype in human fetal spinal cord cultures

Brain Research

Volumn 1137, Issue 1, 2007, Pages 50-57

  Ducray, Angélique D ^a   Qualls, Rachel ^a   Schlattner, Uwe ^b,c   Andres, Robert H ^a   Dreher, Ekkehard ^a   Seiler, Rolf W ^a   Wallimann, Theo ^b   Widmer, Hans Rudolf ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c INSERM   (France)

Author keywords

ChAT; Creatine; Creatine kinase; Culture; GABA; Human spinal cord

Indexed keywords

4 AMINOBUTYRIC ACID; CREATINE; MITOCHONDRIAL CREATINE KINASE;

ARTICLE; BRAIN; CELL DENSITY; CONCEPTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GABAERGIC SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; STEM CELL;

AGE FACTORS; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; CREATINE; CREATINE KINASE, MM FORM; FETUS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; ORGAN CULTURE TECHNIQUES; SPINAL CORD;

EID: 33846908343     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.12.038     Document Type: Article

References (36)

1. Almeida L.S., Salomons G.S., Hogenboom F., Jakobs C., and Schoffelmeer A.N.M. Exocytotic release of creatine in rat brain. Synapse 60 2 (2006) 118-123
2. Andres R.H., Schlattner A.W., Pérez-Bouza U., Krebs A., Seiler S.H., Wallimann R.W., and Widmer T. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. Neuroscience 133 (2005) 701-713
3. Andres R.H., Ducray A.D., Huber A.W., Pérez-Bouza A., Krebs S.H., Schlattner U., Seiler R.W., Wallimann T., and Widmer H.R. Effects of creatine treatment on survival and differentiation of GABAergic neurons in cultured striatal tissue. J. Neurochem. 95 1 (2005) 33-45
4. Andres R.H., Ducray A.D., Pérez-Bouza A., Schlattner U., Huber A.W., Krebs S.H., Seiler R.W., Wallimann T., and Widmer H.R. Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system. Cell Transplant 14 8 (2005) 537-550
5. Boero J., Qin W., Cheng J., Woolsey T.A., Strauss A.W., and Khuchua Z. Restricted neuronal expression of ubiquitous mitochondrial creatine kinase: changing patterns in development and with increased activity. Mol. Cell. Biochem. 244 (2003) 69-76
6. Brewer G.J., and Wallimann T.W. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74 (2000) 1968-1978
7. Brustovetsky N., Brustovetsky T., and Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76 2 (2001) 425-434
8. Chen L., Roberts R., and Friedmann D.L. Expression of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in the fetal rat brain: evidence for a nuclear energy shuttle. J. Comp. Neurol. 363 3 (1995) 389-401
9. Dickmeis T., Rastegar S., Aanstad P., Clark M., Fischer N., Plessy C., Rosa F., Korzh V., and Strahle U. Expression of brain subtype creatine kinase in the zebrafish embryo. Mech. Dev. 109 2 (2001) 409-412
10. Dolder M., Walzel B., Speer O., Schlattner U., and Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278 (2003) 17760-17766
11. Dupuis L., Oudart H., René F., Gonzalez de Aguilar J.L., and Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. U. S. A. 101 30 (2004) 11159-11164
12. Evtouchenko L., Studer L., Spenger C., Dreher E., and Seiler R.W. A mathematical model for the estimation of human embryonic and fetal age. Cell Transplant 5 (1996) 453-464
13. Friedman D.L., and Roberts R. Compartmentation of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: evidence for a creatine phosphate energy shuttle in adult rat brain. J. Comp. Neurol. 343 (1994) 500-511
14. Hausmann O.N., Fouad K., Wallimann T., and Schwab M.E. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spinal Cord 40 9 (2002) 449-456
15. Hemmer W., and Wallimann T. Functional aspects of creatine kinase in brain. Dev. Neurosci. 15 3-5 (1993) 249-260
16. Holtzman D., Tsuji M., Wallimann T., and Hemmer W. Functional maturation of creatine kinase in rat brain. Dev. Neurosci. 15 (1993) 261-270
17. Kleefstra T., Rosenberg E.H., Salomons G.S., Stroink H., van Bokhoven H., Hamel B.C., and de Vries B.B. Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin. Genet. 68 4 (2005) 379-381
18. Kleitman N., Wood P., and Bunge R. In: Banker G., and Goslin K. (Eds). Culturing Nerve Cells. 2nd ed. (1998), Massachusetts Institute of Technology 562-563
19. Klivenyi P., Kiaei M., Gardian G., Calingasan N.Y., and Beal M.F. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem. 88 3 (2004) 576-582
20. Klivenyi P., Calingasan N.Y., Starkov A., Stavrovskaya I.G., Kristal B.S., Yang L., Wieringa B., and Beal M.F. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiol. Dis. 15 (2004) 610-617
21. Mattaredona E.R., Meyer M., Seiler R.W., and Widmer H.R. CGP 3466 increases survival of cultured fetal dopaminergic neurons. Restor. Neurol. Neurosci. 21 1-2 (2003) 29-37
22. Nakamura M., Okano H., Toyama Y., Dai H.N., Finn T.P., and Bregman B.S. Transplantation of embryonic spinal cord-derived neurospheres support growth of supraspinal projections and functional recovery after spinal cord injury in the neonatal rat. J. Neurosci. Res. 81 4 (2005) 457-468
23. Prass K., Royl G., Lindauer U., Freyer D., Megow D., Dirnagl U., Stockler-Ipsiroglu G., Wallimann T., and Priller J. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J. Cereb. Blood Flow Metab. (2006) Jun 14; [Epub ahead of print]
24. Sakellaris G., Kotsiou M., Tamiolaki M., Kalostos G., Tsapaki E., Spanaki M., Spilioti M., Charissis G., and Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. J. Trauma 61 2 (2006) 322-329
25. Schlattner U., and Wallimann T. A quantitative approach to membrane binding of human ubiquitous mitochondrial creatine kinase using surface plasmon resonance. J. Bioenerg. Biomembr. 32 1 (2000) 123-131
26. Schlattner U., Reinhart C., Hornemann T., Tokarska S., and Wallimann T. Isoenzyme-directed selection and characterization of anti-creatine kinase single chain Fv antibodies from a human phage display library. Biochem. Biophys. Acta 1579 (2002) 124-132
27. Schlattner U., Tokarska-Schlattner M., and Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 1762 (2006) 164-180
28. Sistermans E.A., de Kok Y.J., Peters W., Ginsel L.A., Jap P.H., and Wieringa B. Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry. Cell Tissue Res. 280 (1995) 435-446
29. Spenger C., Studer L., Evtouchenko L., Egli M., Burgunder J., Markwalder R., and Seiler R.W. Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon. J. Neurosci. Methods 54 1 (1994) 63-73
30. Streijger F., Oerlemans F., Ellenbroek B.A., Jost C.R., Wieringa B., and Van der Zee C.E. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav. Brain Res. 157 2 (2005) 219-234
31. Wallimann T., and Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133-134 (1994) 193-220
32. Wallimann T., Wyss M., Brdiczka D., Nicolay K., and Eppenberger H. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281 (1992) 21-40
33. Wallimann T., Schlattner U., Guerrero L., and Dolder M. The phosphocreatine circuit and creatine supplementation, both come of age!. In: Mori A., Ishida M., and Clarke J.F. (Eds). Guanidino Compounds vol. 5 (1999), Blackwell Science Asia PTY Ltd, Tokyo 117-229
34. Wendt S., Dedeoglu A., Speer O., Wallimann T., Beal M.F., and Andreassen O.A. Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radical Biol. Med. 32 9 (2002) 920-926
35. Widenfalk J., Widmer H.R., and Spenger C. GDNF, RET and GFRalpha-1-3 mRNA expression in the developing human spinal cord and ganglia. NeuroReport 10 (1999) 1433-1439
36. Zhang W., Narayanan M., and Friedlander R.M. Additive neuroprotective effects of monocycline with creatine in a mouse model of ALS. Ann. Neurol. 53 (2003) 267-270